文献速递生殖医学产科母胎医学

辅助生殖中单胚胎与双胚胎移植后双绒双羊双胎的临床结局

Clinical outcomes of dichorionic diamniotic twin pregnancies following single versus double embryo transfer in human medically assisted reproduction.
PubMed 文献 · Hum Reprod · 2026-01-01

该单中心回顾性队列研究分析了2014至2024年间206例临床多胎妊娠,比较辅助生殖中单胚胎移植(SET)与双胚胎移植(DET)所致双绒双羊(DCDA)双胎的临床和围产结局。结果显示SET组完全流产率显著更高、双胎活产率更低。围产结局如孕龄、出生体重和先天异常率组间无显著差异。

要点

  • SET来源的DCDA双胎完全流产率49.0%,显著高于DET的17.7%。
  • SET来源的DCDA双胎双胎活产率17.6%,显著低于DET的53.1%。
  • 两组围产结局(孕龄、出生体重、先天异常率)无显著差异。

核心结论

  • 在DCDA双胎妊娠中,SET与完全流产发生率显著升高和双胎活产率降低相关。
  • DCDA双胎妊娠在辅助生殖中不应被视为统一的临床实体。

研究设计与样本

  • 仅纳入使用自体卵母细胞的周期,比较SET与DET来源的DCDA双胎的临床和围产结局。
  • 采用Mann-Whitney U检验和Fisher精确检验,P<0.05为显著,并进行探索性多变量logistic回归分析。

主要发现

  • DET组两个孕囊和两个胎心的发生率显著高于SET组(98.0% vs 47.2%,P<0.0001;63.5% vs 25.5%,P<0.0001)。
  • 两个胎心的调整比值比(aOR)为0.276(95%CI 0.108-0.706,P<0.007)。
  • DET来源DCDA双胎活产率53.1%,SET来源17.6%(P<0.0001;aOR 0.324,95%CI 0.121-0.867,P=0.025)。
  • SET后完全流产更常见(49.0% vs 17.7%,P<0.0001;aOR 9.140,95%CI 3.030-27.600,P<0.0001)。
  • 围产结局包括孕龄、出生体重和先天异常率组间无显著差异。

临床怎么用

  • 临床咨询时应告知SET来源的DCDA双胎完全流产风险更高、双胎活产率更低。
  • SET仍是预防多胎妊娠的最佳策略,但需进一步识别移植后分裂风险较高的胚胎并完善MZT预防标准。

局限性

  • 单卵双胎病例数有限,且未能通过遗传学确认卵性。
  • 部分同性DCDA双胎可能为双卵来源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Do clinical and perinatal outcomes of dichorionic diamniotic (DCDA) twin pregnancies differ between single embryo transfer (SET) and double embryo transfer (DET) in human medically assisted reproduction (MAR)? SUMMARY ANSWER: In DCDA twin pregnancies, SET was associated with a significantly higher incidence of complete miscarriage and a lower rate of twin live births than DET. WHAT IS KNOWN ALREADY: While DET has historically been the major contributor to dizygotic DCDA twins, the global adoption of SET has markedly reduced such cases. However, monozygotic twinning (MZT) occurs more frequently after MAR, especially in blastocyst transfer cycles, and the prognosis of monozygotic DCDA twins remains poorly understood. STUDY DESIGN, SIZE, DURATION: This single-center retrospective cohort study analyzed 206 clinical multiple pregnancies achieved between January 2014 and December 2024, following 4658 fresh and 15 872 frozen-warmed embryo transfer cycles. PARTICIPANTS/MATERIALS, SETTING, METHODS: Only cycles using autologous oocytes were included. Clinical and perinatal outcomes of DCDA twin pregnancies derived from SET and DET were compared. To account for baseline differences between SET and DET groups, an exploratory multivariable logistic regression analysis was performed for clinical outcomes. Statistical analyses were performed using the Mann-Whitney U-test and Fisher's exact test, with P < 0.05 considered significant. MAIN RESULTS AND THE ROLE OF CHANCE: When comparing the clinical course of DCDA twin pregnancies, the incidence of two gestational sacs and two fetal heartbeats was significantly higher in the DET group than in the SET group (98.0% vs 47.2%, P < 0.0001; 63.5% vs 25.5%, P < 0.0001) (two fetal heartbeats: adjusted odds ratios [aOR], 0.276; 95% CI, 0.108-0.706; P < 0.007). Twin live birth occurred in 53.1% of DET-derived DCDA twins and 17.6% of SET-derived DCDA twins (P < 0.0001) (aOR, 0.324; 95% CI, 0.121-0.867; P = 0.025), whereas complete miscarriage was more frequent after SET (49.0% vs 17.7%, P < 0.0001) (aOR, 9.140; 95% CI, 3.030-27.600; P < 0.0001). Perinatal outcomes, including gestational age, birth weight, and congenital anomaly rates, did not differ significantly between groups. LIMITATIONS, REASONS FOR CAUTION: The number of monozygotic cases was limited, and zygosity could not be genetically confirmed. Some same-sex DCDA twins may have been dizygotic in origin. WIDER IMPLICATIONS OF THE FINDINGS: These findings highlight that DCDA twin pregnancies should not be regarded as a uniform clinical entity in MAR. Even within the same chorionicity category, early outcomes differ significantly between monozygotic twins after SET and dizygotic twins after DET. Although SET remains the optimal strategy to prevent multiple pregnancies, further studies should aim to identify embryos at higher risk of post-transfer splitting and to refine preventive criteria for MZT. STUDY FUNDING/COMPETING INTEREST(S): There is no funding for this study. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Hattori H, Goto Y, Kasahara Y, et al. Clinical outcomes of dichorionic diamniotic twin pregnancies following single versus double embryo transfer in human medically assisted reproduction. Hum Reprod. 2026. PMID: 41782376. doi:10.1093/humrep/deag031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。